Addressing current challenges in optimization of lipid management following an ACS event: Outcomes of the ACS EuroPath III initiative

BACKGROUND: Low‐density lipoprotein cholesterol (LDL‐C) lowering is key to reduce atherosclerotic disease progression and recurrent events for patients after acute coronary syndrome (ACS). However, LDL‐C management for post‐ACS patients remains challenging in clinical practice. HYPOTHESIS: The ACS E...

Descripción completa

Detalles Bibliográficos
Autores principales: Catapano, Alberico L., De Caterina, Raffaele, Jukema, J. Wouter, Klempfner, Robert, Landmesser, Ulf, Schiele, François, Sionis, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106658/
https://www.ncbi.nlm.nih.gov/pubmed/36799113
http://dx.doi.org/10.1002/clc.23988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106658/
https://www.ncbi.nlm.nih.gov/pubmed/36799113
http://dx.doi.org/10.1002/clc.23988

Ejemplares similares